Product Information
TEMAZEPAM 22.5 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $1.6901 per EA under NDC 67877014930. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 21, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
22.5 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877014930
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457FDA Approved
4/21/1987
TE Code
AB
On Market Since
6/28/2012
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 22.5 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6901 per EA |
|---|---|
| All-time high | $5.9577 (Mar 11, 2015) |
| All-time low | $1.1572 (Nov 20, 2024) |
| 52-week high | $2.0272 |
| 52-week low | $1.5147 |
| Median price | $3.2207 |
| Average price | $3.3997 |
| Largest weekly change | +81.6% (Mar 23, 2022) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 22.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 22.5 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $1.6901 per EA (NDC 67877014930), effective Aug 19, 2026.
How has the price of TEMAZEPAM 22.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has declined 65.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 22.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has ranged from a low of $1.1572 (Nov 20, 2024) to a high of $5.9577 (Mar 11, 2015), with a median of $3.2207 per EA.
Are there cheaper alternatives to TEMAZEPAM 22.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 22.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 22.5 MG CAPSULE?
TEMAZEPAM 22.5 MG CAPSULE (NDC 67877014930) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.